Registration
 
All news
Top Stories
Editors' Picks
Stocks
Crypto
Economics
Currencies
Commodities
Business & Wealth
Market Voices
Andreas Kristo
Andreas Kristo

Artiva Biotherapeutics, Inc. early AlloNK plus rituximab results show outpatient potential

Artiva Biotherapeutics, Inc. early AlloNK plus rituximab results show outpatient potential
Artiva reveals immune reset results

Artiva Biotherapeutics, Inc. is advancing efforts to expand access to immune reset therapies through scalable solutions.

The company’s investigational AlloNK combined with rituximab produced early clinical responses, as reported in its #EULAR2026 data highlighted by Cell & Gene. The therapy features an off-the-shelf, outpatient profile, signaling potential for wider patient access within immunotherapy treatment. Additional details on clinical efficacy and broader adoption strategies are expected as trials progress.

Artiva Biotherapeutics, Inc. previously secured FDA RMAT designation for its AlloNK plus rituximab program in autoimmune disease, as reported in Q2 2026 results. The regulatory status supports ongoing clinical development. The company's strategy remains focused on scalable, off-the-shelf immunotherapies in outpatient settings.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

How China is turning AI credits into Singles’ Day’s newest staple
  • By Dmytro Kharkov
  • 1 hour ago
How China is turning AI credits into Singles’ Day’s newest staple
Editors' Picks
Banks vs. crypto companies: Who better protects your money from hackers?
  • By Elena Nikulina
  • 4 hours ago
Banks vs. crypto companies: Who better protects your money from hackers?
Editors' Picks
U.S. elections: What awaits the crypto industry after the Democrats' victory?
  • By Eugene Komchuk
  • 7 hours ago
U.S. elections: What awaits the crypto industry after the Democrats' victory?
Editors' Picks
All Editors' Top Picks

Latest Artiva News

Artiva Biotherapeutics discontinues AlloNK development and reviews strategic alternatives
  • By Ksenia Gerey
  • 27.10.2026
Artiva Biotherapeutics discontinues AlloNK development and reviews strategic alternatives
Companies
#Artiva
AlloNK plus rituximab delivers clinically meaningful gains in early Sjögren disease study, Artiva Biotherapeutics finds
  • By Ksenia Gerey
  • 01.10.2026
AlloNK plus rituximab delivers clinically meaningful gains in early Sjögren disease study, Artiva Biotherapeutics finds
Companies
#Artiva
FDA RMAT designation for AlloNK plus rituximab boosts Artiva Biotherapeutics, Inc. clinical progress
  • By Ashutosh Sureka
  • 06.08.2026
FDA RMAT designation for AlloNK plus rituximab boosts Artiva Biotherapeutics, Inc. clinical progress
Companies
#Artiva
All Artiva News
  • Dmytro Kharkov
  • 1 hour ago
How China is turning AI credits into Singles’ Day’s newest staple
  • Elena Nikulina
  • 4 hours ago
Banks vs. crypto companies: Who better protects your money from hackers?
  • Eugene Komchuk
  • 7 hours ago
U.S. elections: What awaits the crypto industry after the Democrats' victory?
  • Anastasiia Chabaniuk
  • Yesterday
From Coinbase to Visa: Who makes money from blockchain?
  • Mikhail Vnuchkov
  • Yesterday
One of the biggest M&A deals: Why is Marvell buying Lumentum?
  • Alena Volkova
  • 6 min ago
People acquire Bitcoin out of fear and spite toward government, Francis Pouliot notes
  • Oksana Koneva
  • 37 min ago
Holding during bitcoin downturns is hard, Jimmy Song notes
  • Yulia Slavina
  • 41 min ago
San Francisco Bay Area rents continue to rise, two major REITs say
  • Oksana Koneva
  • 51 min ago
Dan Ives: AI revolution outlook unchanged as slower datacenter and Capex pace seen as bullish
  • Alena Volkova
  • 1 hour ago
Anas Alhajji: EIA reports crude stocks fell by 0.9 million barrels
Top News
  • Oleksii Zaichenko
  • 55 min ago
Bitcoin tops $80,500 as U.S. stocks rally after midterm elections
Bitcoin tops $80,500 as U.S. stocks rally after midterm elections
  • Dmytro Kharkov
  • 1 hour ago
How China is turning AI credits into Singles’ Day’s newest staple
How China is turning AI credits into Singles’ Day’s newest staple
  • Andrey Mastykin
  • 2 hours ago
Oil extends losses as U.S. midterm results fuel Iran peace hopes
Oil extends losses as U.S. midterm results fuel Iran peace hopes
  • Igor Krasulya
  • 4 hours ago
Wall Street futures soar after Democrats win Congress
Wall Street futures soar after Democrats win Congress
  • Hanna Syniavska
  • 5 hours ago
Eurozone inflation hits three-year high as energy costs fuel price surge
Eurozone inflation hits three-year high as energy costs fuel price surge
Live News
  • Igor Krasulya
  • Now
Demand for Meta debut euro bonds exceeds offering size sixfold
  • Olga Shendetskaya
  • Now
McDonald's reports first sales decline in 18 months
  • Anton Kharitonov
  • Now
EUR/USD tests 1.1270 as U.S. election results and eurozone inflation boost the euro
  • Mykhailo Ihnatenko
  • Now
AMD stock jumps over 6% after record earnings and strong Q4 outlook
  • Eugene Komchuk
  • Now
Morgan Stanley joins Wall Street asset tokenization initiative
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org https://gdpr.eu/ GDPR World Association of News Publishers